PNEUMACRIT Device for Neonatal Cardio Respiratory Monitoring
PNEUMACRIT
Preterm Neonate/ Neonatal Embedded Universal Microelectronic Wearable Acquisition for Cardio Respiratory Intensive Therapy. Clinical Assessment of Device Usability and Reliability
1 other identifier
interventional
20
1 country
1
Brief Summary
The usability of a new PNEUMACRIT system is studied in clinical environment in this feasibility study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2023
CompletedStudy Start
First participant enrolled
November 24, 2023
CompletedFirst Posted
Study publicly available on registry
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2024
CompletedFebruary 28, 2024
February 1, 2024
3 months
November 23, 2023
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion (%) of recording time with high quality EIT-signal
Proportion of time that the collected EIT signal is accurate enough for reliable image reconstruction and observations of changes in lung aeration
6-24 hours
Secondary Outcomes (1)
Staff and parent questionnaires
48 hours
Study Arms (1)
Feasibility of the PNEUMACRIT belt
EXPERIMENTALNeonates will be monitored with a PNEUMACRIT electrode belt for 6 to 24 hours. After the study period, patient parents and nurses will give feedback.
Interventions
Eligibility Criteria
You may qualify if:
- Inpatient at Oulu University Hospital PICU or NICU
- Gestational age at birth over 32 weeks
- Weight 2000-5000g
- Postnatal age \> 12 hours
- Written informed consent from the parents of legal representative
- Non-invasive monitoring of oxygen saturation and ECG
You may not qualify if:
- Postmenstrual age \< 32 weeks
- Weight at time of the study \< 2000g or \> 5000g
- Chest skin lesion preventing safe use of the electrode belt
- Recent chest surgery within the past 7 days (e.g. thoracotomy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oululead
- Middlesex Universitycollaborator
Study Sites (1)
Oulu University Hospital
Oulu, Finland
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Principal investigator, Associate professor of pediatrics
Study Record Dates
First Submitted
November 23, 2023
First Posted
December 15, 2023
Study Start
November 24, 2023
Primary Completion
February 25, 2024
Study Completion
February 25, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share